Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability

A technology of vascular permeability and medicine, which is applied in the field of medicine for the prevention or treatment of eye diseases, and can solve the problems of no research reports

Inactive Publication Date: 2008-12-03
SAPPORO MEDICAL UNIVERSITY
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] However, so far, there has been no research report on the fact that in a co-culture system of astrocytes and vascular endothelial cells, changes in the gene expression of astrocytes caused by specific compounds act paracrinely to alter the expression of endothelial vascular cells. permeability; and in the mouse model of diabetes induced chemically by streptozotocin, the above-mentioned specific compound has a significant effect on the vascular permeability in the state of significant hyperglycemia in the early diabetic group and the middle diabetic group The hyperthyroidism has a significant inhibitory effect, and as a result, it can be effectively used as a preventive and therapeutic medicine for diabetic retinopathy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability
  • Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability
  • Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] Example 1: Regulation and control of GDNF by all-trans retinoic acid

[0074] Often in in vitro studies of astrocytes, the choice of cells used is an important issue. Astrocytes isolated from the human brain can be obtained from the American Cell Bank or the Research Society, but from the nature of the first-generation culture of nervous system cells with more differentiated forms, the cell proliferation is slow, and it is not suitable for gene expression. expression analysis. Therefore, the present inventors conducted an experiment using U373MG cells of human glioma cells, in which GFAP (glial fibrillary acidic protein, glial fibrillary acidic protein) known as a marker of astrocytic differentiation was positive, And it has stable properties as a cell line. U373MG cells are readily available in the market.

[0075] U373MG cells were cultured at high density, treated with 10nM or 100nM all-trans retinoic acid (atRA), mRNA was extracted from the cells for quantitative...

Embodiment 2

[0086] In Example 1, the expression of GDNF also increased (concentration-dependently) as the concentration of atRA increased, and co-culture with vascular endothelial cells was carried out in order to examine whether this change had a physiological response. Such as image 3 As shown, a double chamber (double chamber) using a penetrating hole (Transwell) was constructed. Such as image 3 As indicated, U373MG cells (astrocytes) as effector cells were cultured in the outer chamber, treated with atRA and further cultured for 24 hours. Vascular endothelial cells obtained from bovine brain were cultured in a separately prepared inner chamber, forming a dense cell sheet in advance.

[0087] The outer compartment of U373MG cells was combined with the inner compartment of inner tube endothelial cells to start co-culture, and the barrier function as a connection function of vascular endothelial cells was evaluated. By simultaneously proliferating and culturing two types of cells, t...

Embodiment 3

[0090] From the results of co-culture with vascular endothelial cells in Example 2, it has been clarified that the increased expression of GDNF by atRA has a function on vascular endothelial cells. In the results of preliminary experiments, it has been confirmed that Am580 induces the expression of GDNFmRNA in the same concentration-dependent and time-dependent manner as atRA (refer to the following Figure 6 ). The vascular endothelial cells used in Example 2 are the first-generation cultured cell lines obtained from bovine brain, which has the advantage of being able to reproduce in vitro conditions closer to those in the body. However, unlike so-called cell lines, first-generation cultured cell lines have a limited number of divisions and a slow division rate, and they are not suitable for the experimental system required for repeated verification. Therefore, MDCK (Madin Darby Canine Kidney) cells derived from dog renal tubular cells (which are easily available in the mark...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a pharmaceutical for use in the prevention and / or treatment of an ophthalmic disease induced by the increase in vasopermeability, such as diabetic retinopathy or age-related macular degeneration. The pharmaceutical comprises a retinoid such as all-trans retinoic acid or 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid as an active ingredient.

Description

technical field [0001] The invention relates to a medicine for preventing or treating eye diseases. Specifically, it relates to a product containing a retinoid such as a RARα agonist as an active ingredient, which is effective for the prevention and / or treatment of eye diseases caused by hyperpermeability of blood vessels such as diabetic retinopathy and age-related macular degeneration medicine. Background technique [0002] In recent years, the number of diabetic patients in Japan is reported to be more than 6 million, and the number of patients is increasing. Diabetic retinopathy, one of the three major complications of diabetes, is the number one cause of acquired blindness. It is reported that about 4,000 people become blind every year because of it. It is not only a problem in internal medicine and ophthalmology, but also a big social problem. . Diabetic retinopathy refers to a retinal vascular disease in which hyperpermeability of capillaries, capillary occlusion, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/203A61P27/02A61K31/196
CPCA61K31/196A61K31/203A61P27/02A61P43/00
Inventor 泽田典均小山内诚锦织奈美
Owner SAPPORO MEDICAL UNIVERSITY